Abstract:<h3 class="Heading">Objectives</h3><p class="Para">To assess the value of <sup>18</sup>F-FDG PET and MR-IVIM parameters before and during concurrent chemoradiotherapy (CCRT) for evaluating early treatment response and predicting tumor recurrence in patients with locally advanced cervical cancer (LACC) using a hybrid PET/MR scanner.</p><h3 class="Heading">Methods</h3><p class="Para">Fifty-one patients with LACC underwent pelvic PET/MR scans with an IVIM sequence at two time-points (pretreatment [pre] and midtreatment [mid]). Pre- and mid-PET parameters (SUV<sub>max</sub>, MTV, TLG) and IVIM parameters (<em class="EmphasisTypeItalic">D</em>, <em class="EmphasisTypeItalic">F</em>, <em class="EmphasisTypeItalic">D</em>*) and their percentage changes (Δ%SUV<sub>max</sub>, Δ%MTV, Δ%TLG, Δ%<em class="EmphasisTypeItalic">D</em>, Δ%<em class="EmphasisTypeItalic">F</em>, Δ%<em class="EmphasisTypeItalic">D</em>*) were calculated. We selected independent imaging parameters and built a combined prediction model incorporating imaging parameters and clinicopathological risk factors. The performance of the combinative evaluation for tumor early shrinkage rates (TESR) and the prediction model for tumor recurrence was assessed.</p><h3 class="Heading">Results</h3><p class="Para">Thirty-two patients were classified into the good response (GR) group with TESR ≥ 50%, and 19 patients were categorized into the poor response (PR) group with TESR < 50%. Δ%<em class="EmphasisTypeItalic">D</em> (<em class="EmphasisTypeItalic">p</em> = 0.013) and Δ%<em class="EmphasisTypeItalic">F</em> (<em class="EmphasisTypeItalic">p</em> = 0.006) are independently related to TESR with superior combined diagnostic ability (AUC = 0.901). Pre-TLG, Δ%<em class="EmphasisTypeItalic">D</em>, and suspicious lymph node metastasis (SLNM) were selected for the construction of the combined prediction model. The model for identifying the patients with high risk of tumor recurrence reached a moderate predictive ability and good stability with c-index of 0.764 (95% CI, 0.672–0.855).</p><h3 class="Heading">Conclusion</h3><p class="Para">The combined prediction model based on pretreatment PET metabolic parameter (pre-TLG), IVIM-D percentage changes, and LNs status provides great potential to identify the LACC patients with high risk of recurrence at early stage of CCRT.</p><h3 class="Heading">Key Points</h3><p class="Para">• <em class="EmphasisTypeItalic">PET/MR plus IVIM offers various complementary information for LACC.</em></p><p class="Para">• <em class="EmphasisTypeItalic">IVIM-D and IVIM-F percentage changes are independently related to tumor early shrinkage rates.</em></p><p class="Para">• <em class="EmphasisTypeItalic">The combined prediction model can help identify the LACC patients with high risk of tumor recurrence.</em></p>

IVIM-DWI and MRI-based Radiomics in Cervical Cancer: Prediction of Concurrent Chemoradiotherapy Sensitivity in Combination with Clinical Prognostic Factors

Radiomics Analysis of Contrast-Enhanced CT for the Preoperative Prediction of Microvascular Invasion in Mass-Forming Intrahepatic Cholangiocarcinoma

Can the Combination of DWI and T2WI Radiomics Improve the Diagnostic Efficiency of Cervical Squamous Cell Carcinoma?

Predictive and prognostic value of intravoxel incoherent motion (IVIM) MR imaging in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy

Predicting and Early Monitoring Treatment Efficiency of Cervical Cancer under Concurrent Chemoradiotherapy by Intravoxel Incoherent Motion Magnetic Resonance Imaging

Evaluating Early Response of Cervical Cancer under Concurrent Chemo-Radiotherapy by Intravoxel Incoherent Motion MR Imaging.

Intravoxel Incoherent Motion (IVIM) MR Quantification in Locally Advanced Cervical Cancer (LACC): Preliminary Study on Assessment of Tumor Aggressiveness and Response to Neoadjuvant Chemotherapy

Multimodal MRI-based deep-radiomics model predicts response in cervical cancer treated with neoadjuvant chemoradiotherapy

Predicting treatment response to concurrent chemoradiotherapy in squamous cell carcinoma of the cervix using amide proton transfer imaging and intravoxel incoherent motion imaging

Planning CT-based Radiomics for the Prediction of Tumor Response to IMRT in Locally Advanced Cervical Cancer

Multiparametric PET/MR (PET and MR-IVIM) for the evaluation of early treatment response and prediction of tumor recurrence in patients with locally advanced cervical cancer

Multi-Parametric Magnetic Resonance Imaging-Based Radiomics Analysis of Cervical Cancer for Preoperative Prediction of Lymphovascular Space Invasion

Intravoxel Incoherent Motion Magnetic Resonance Imaging for Diagnosis of Cervical Cancer and Evaluation of Response of Uterine Cervical Cancer to Radiochemotherapy: A Pilot Study

Added-value of dynamic contrast-enhanced MRI on prediction of tumor recurrence in locally advanced cervical cancer treated with chemoradiotherapy

Comprehensive assessment of postoperative recurrence and survival in patients with cervical cancer

Radiomics analysis for prediction of lymph node metastasis after neoadjuvant chemotherapy based on pretreatment MRI in patients with locally advanced cervical cancer

Feasibility of MRI-based Radiomics Features for Predicting Lymph Node Metastases and VEGF Expression in Cervical Cancer.

Machine Learning-Based Radiomics for Predicting Outcomes in Cervical Cancer Patients Undergoing Concurrent Chemoradiotherapy

A MRI radiomics-based model for prediction of pelvic lymph node metastasis in cervical cancer

Multiparametric mri-based radiomics nomogram for predicting lymph-vascular space invasion in cervical cancer

Diagnostic Value of Combined Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging with Diffusion Tensor Imaging in Predicting Parametrial Infiltration in Cervical Cancer